Carvas 25mg Tablet

Tablet
Rs.53.30for 1 strip(s) (10 tablets each)
1
Unfortunately, we don't have any more items in stock
Report Error

Composition FOR Carvas 25mg Tablet

Carvedilol(25mg)

food interaction for Carvas Tablet

alcohol interaction for Carvas Tablet

pregnancy interaction for Carvas Tablet

lactation interaction for Carvas Tablet

food
alcohol
pregnancy
lactation
Carvas 25mg Tablet is to be taken with food.
None
CAUTION
It is unsafe to consume alcohol with Carvas 25mg Tablet.
UNSAFE
Carvas 25mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
CONSULT YOUR DOCTOR
Carvas 25mg Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
SAFE IF PRESCRIBED

SALT INFORMATION FOR Carvas 25mg Tablet

Carvedilol(25mg)

Carvas tablet uses

How carvas tablet works

Carvas 25mg Tablet is an alpha and beta blocker. It works by slowing down the heart rate and relaxing blood vessels which makes the heart more efficient at pumping blood around the body.

Common side effects of carvas tablet

Decreased blood pressure, Headache, Fatigue, Dizziness, Breathlessness

SUBSTITUTES FOR Carvas Tablet

17 Substitutes
17 Substitutes
Sorted By
RelevancePrice

Expert advice FOR Carvas Tablet

  • It should be taken with food.
  • Check your blood pressure 1 week after starting Carvedilol, and inform your doctor if it has not improved.
  • Carvedilol may cause dizziness or sleepiness. Do not drive or do anything requiring concentration until you know how it affects you.
  • It is best to avoid drinking alcohol while taking Carvedilol as it may make the side effects worse.
  • Do not stop taking Carvedilol suddenly as it can cause your blood pressure to rise suddenly, thereby increasing the risk of heart attack and stroke.

Frequently asked questions FOR Carvas 25mg Tablet

Carvedilol

Q. What happens when you stop taking Carvas 25mg Tablet?
Carvas 25mg Tablet needs to be taken regularly as directed by your doctor. Suddenly stopping it may cause chest pain or heart attack. Your doctor may slowly lower your dose over a period of time before stopping it completely if required.
Q. Does Carvas 25mg Tablet make you tired?
Yes, Carvas 25mg Tablet may make you tired as well as dizzy. These may occur initially when you start the treatment or when the dose is increased. If you experience these symptoms you should not drive or operate machinery.
Q. Can Carvas 25mg Tablet cause weight gain?
Yes, weight gain is a common side effect of Carvas 25mg Tablet, but it does not occur in everyone. If you are taking Carvas 25mg Tablet for heart failure, tell your doctor if you gain weight or have trouble breathing, as this may be a sign of fluid retention.
Show More
Q. Can Carvas 25mg Tablet cause kidney failure?
Use of Carvas 25mg Tablet in patients with heart failure can rarely lead to deterioration of kidney function. However, Carvas 25mg Tablet may cause risk of kidney failure in patients with low blood pressure (systolic blood pressure less than 100 mm Hg), patients with hardening of the arteries and/or having heart disease, or already have impaired kidney function. Such patients should be closely monitored during treatment with Carvas 25mg Tablet. Although, kidney functions return to baseline when Carvas 25mg Tablet is stopped.
Q. Can a diabetic patient take Carvas 25mg Tablet?
Yes, a diabetic patient can take Carvas 25mg Tablet, provided that there is a regular check on blood glucose levels. It has been noted that in well-controlled diabetes mellitus with mild to moderate hypertension, Carvas 25mg Tablet did not have any effect on blood glucose levels. However, it is important to know that, using Carvas 25mg Tablet class of medicines (beta-blockers) may hide the symptoms of hypoglycemia (decrease in glucose levels), especially an increase in heartbeat or palpitations. In addition to that, Carvas 25mg Tablet may cause worsening of hyperglycemia (increase in blood glucose levels) in patients with heart failure and diabetes. Hence, it is recommended that blood glucose should be monitored while initiating, adjusting, or discontinuing the dose of Carvas 25mg Tablet. Inform the doctor if there is any change in blood glucose levels during Carvas 25mg Tablet therapy.
Q. Can I take Carvas 25mg Tablet empty stomach?
It is recommended that you take Carvas 25mg Tablet with food, as food decreases the rate at which the medicine gets absorbed by the body. This will help to reduce the chances of orthostatic hypotension (low blood pressure which may cause dizziness or fainting when you stand up).
Q. What are the serious side effects of Carvas 25mg Tablet?
Carvas 25mg Tablet may cause serious side effects such as fainting, shortness of breath, weight gain, swelling of the arms, hands, feet, ankles, or lower legs. Some may also experience chest pain, slow or irregular heartbeat, rash, hives, itching, and difficulty in breathing and swallowing. If you experience any of these symptoms call your doctor immediately.
Q. What if I take more than the recommended dose of Carvas 25mg Tablet?
If you take more than the recommended dose of Carvas 25mg Tablet you may experience slow heartbeat, dizziness, fainting, difficulty breathing, vomiting, and loss of consciousness or seizures. Contact your doctor and seek immediate medical help in a nearby hospital.
Q. Who should not take Carvas 25mg Tablet?
Carvas 25mg Tablet should be avoided if the patient has severe heart failure and is hospitalized in the intensive care unit or require certain intravenous medications that help support circulation (inotropic medications). In addition to that, Carvas 25mg Tablet should be avoided in patients who are prone to asthma or other breathing problems, have a slow heartbeat or irregular heartbeat, have liver problems, and are allergic to Carvas 25mg Tablet.

Content on this page was last updated on 11 November, 2024, by Dr. Varun Gupta (MD Pharmacology)